MIPS Project Detail:

Company
Company Description:
Nutramax Laboratories researches, develops, and markets high-quality products to support the active lifestyles of people and animals. The company’s flagship products include the Cosamin® and Cosequin® joint health supplements. Nutramax Laboratories’ products are sold in food and drug stores, mass retailers, warehouse club stores, veterinarians, pet specialty retailers and online.

MIPS Project
Chewable Cosequin Tablet
Project #
2032
|
MIPS Round
20
|
Starting Date:
Aug 1997
MIPS Project Challenge:
Nutramax sought to determine bioavailability/bioequivalence and pharmacokinetic studies needed for Cosamin® and Cosequin® to gain FDA approval.
Project Scope:
Natalie Eddington worked to develop the chewable tablet formulation of Cosequin® for dogs and bioequivalency study needed to support a new animal drug application for Cosqeuin®. She generated pharmacokinetic data to support the NDA for Cosamin®.

Results:
Cosamin® has been shown effective in peer-reviewed, controlled, published U.S. studies, and consistently shown to meet label claim. Cosamin® DS is available at leading pharmacies nationwide.
Principal Investigator:
Natalie
Eddington
Project Manager:
Pete
Patras
Director
Technologies:
Biotechnology / Genetic Engineering